potential products Press Release

Title Picture
01/30/2018 - 16:54
U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENT FOR LEAPS VACCINE PLATFORM TECHNOLOGY
Cel-Sci's picture
Cel-Sci
01/28/2018 - 23:34
Epson Named Among Top 100 Global Innovators for Seventh Consecutive Year
Epson's picture
Epson
01/16/2018 - 12:34
CEL-SCI ANNOUNCES ADJUSTMENT TO WARRANT EXERCISE PRICE
Cel-Sci's picture
Cel-Sci
01/08/2018 - 12:06
CEL-SCI AWARDED PATENT FOR LEAPS VACCINE IN TREATMENT OF RHEUMATOID ARTHRITIS
Cel-Sci's picture
Cel-Sci
12/29/2017 - 15:05
CEL-SCI REPORTS FISCAL 2017 FINANCIAL RESULTS AND CLINICAL & CORPORATE DEVELOPMENTS
Cel-Sci's picture
Cel-Sci
12/19/2017 - 03:55
Boehringer Ingelheim enters into collaboration with Roche to partner for inflammatory bowel diseases
Boehringer Ingelheim's picture
Boehringer-Ingelheim
12/18/2017 - 16:18
CEL-SCI ANNOUNCES ROBERT WATSON JOINS ITS BOARD OF DIRECTORS
Cel-Sci's picture
Cel-Sci
12/11/2017 - 12:48
CEL-SCI REACHES FULL ENROLLMENT IN PIVOTAL PHASE 3 HEAD AND NECK CANCER STUDY
Cel-Sci's picture
Cel-Sci
12/07/2017 - 08:01
Five Future Truths of Digital Signage in Retail
Digital Signage Federation's picture
Digital Signage...
11/13/2017 - 12:13
CEL-SCI ANNOUNCES UPDATE ON ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
Cel-Sci's picture
Cel-Sci
10/10/2017 - 05:54
CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE'S MECHANISM OF ACTION IN MAKING TUMORS 'VISIBLE' TO THE IMMUNE SYSTEM
Cel-Sci's picture
Cel-Sci
10/05/2017 - 09:17
CEL-SCI ANNOUNCES UPDATE ON ONGOING ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
Cel-Sci's picture
Cel-Sci
09/19/2017 - 04:54
CEL-SCI ANNOUNCES $1.5 MILLION NIH SBIR GRANT TO SUPPORT DEVELOPMENT OF RHEUMATOID ARTHRITIS VACCINE
Cel-Sci's picture
Cel-Sci
08/23/2017 - 09:03
CEL-SCI ANNOUNCES $3.5 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
08/14/2017 - 05:53
U.S. FDA REMOVES CLINICAL HOLD ON CEL-SCI'S PHASE 3 HEAD & NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
07/06/2017 - 04:22
DIA Announces Industry Days for Artificial Intelligence, Big Data Experts
Defense Intelligence Agency's picture
DIA
06/27/2017 - 03:38
Sandoz receives approval in Europe for Erelzi (biosimilar etanercept) to treat multiple inflammatory diseases
Novartis's picture
Novartis
06/12/2017 - 13:22
CEL-SCI ANNOUNCES REVERSE STOCK SPLIT
Cel-Sci's picture
Cel-Sci
06/08/2017 - 08:33
CEL-SCI ANNOUNCES NEW DATA FOR ITS RHEUMATOID ARTHRITIS VACCINE CANDIDATE PUBLISHED IN PEER REVIEWED JOURNAL
Cel-Sci's picture
Cel-Sci
06/05/2017 - 06:20
CEL-SCI SUBMITS FDA RESPONSE FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
05/16/2017 - 11:44
CEL-SCI SCIENTIST PRESENTS AT AAI - IMMUNOLOGY 2017 MEETING
Cel-Sci's picture
Cel-Sci
05/03/2017 - 04:15
AstraZeneca and Pieris Pharmaceuticals collaborate to develop and commercialise Anticalin-based inhaled treatments for respiratory diseases
AstraZeneca's picture
AstraZeneca
05/01/2017 - 10:20
CEL-SCI ANNOUNCES $1.51 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
04/28/2017 - 09:11
CEL-SCI RECEIVES INTENT TO GRANT NOTICE FOR NEW MULTIKINE PATENT FROM THE EUROPEAN PATENT OFFICE
Cel-Sci's picture
Cel-Sci
04/13/2017 - 12:38
NMSUs AgSprint accelerator selects first participants
New Mexico State University's picture
New Mexico Stat...
04/12/2017 - 05:18
CEL-SCI SCIENTIST PRESENTS AT THE WORLD VACCINE CONGRESS
Cel-Sci's picture
Cel-Sci
03/09/2017 - 08:04
CEL-SCI ANNOUNCES $1.5 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
03/08/2017 - 05:01
Acquisition brings $15.2 million CPRIT grant to fund 70-patient Phase I trial
Heat Biologics's picture
Heat Biologics
03/06/2017 - 12:28
CEL-SCI GIVES UPDATE ON PARTIAL CLINICAL HOLD ON PHASE 3 HEAD AND NECK CANCER STUDY WITH MULTIKINE
Cel-Sci's picture
Cel-Sci
02/21/2017 - 12:57
CEL-SCI SCIENTIST PRESENTS NEW FINDINGS FOR RHEUMATOID ARTHRITIS TREATMENT VACCINE AT CONFERENCE
Cel-Sci's picture
Cel-Sci
02/17/2017 - 10:47
CEL-SCI ANNOUNCES $1.0 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
12/20/2016 - 08:48
CEL-SCI ANNOUNCES CLOSING OF PUBLIC OFFERING AND RECEIVES AUDIT OPINION WITH GOING CONCERN EXPLANATION
Cel-Sci's picture
Cel-Sci
12/14/2016 - 18:02
CEL-SCI REPORTS FISCAL 2016 FINANCIAL RESULTS AND CLINICAL & CORPORATE DEVELOPMENTS
Cel-Sci's picture
Cel-Sci
11/21/2016 - 18:41
CEL-SCI SUBMITS RESPONSE TO FDA IN CONNECTION WITH PARTIAL CLINICAL HOLD ON PHASE 3 CLINICAL TRIAL
Cel-Sci's picture
Cel-Sci
11/14/2016 - 07:56
CEL-SCI REPORTS PRECLINICAL DATA SHOWING LEAPS VACCINE IS SUCCESSFUL IN TREATING RHEUMATOID ARTHRITIS
Cel-Sci's picture
Cel-Sci
10/21/2016 - 06:48
CEL-SCI PROVIDES UPDATE ON PARTIAL CLINICAL HOLD ON PHASE 3 CLINICAL TRIAL
Cel-Sci's picture
Cel-Sci
10/04/2016 - 14:06
HHS sponsors commercial manufacturing tests for Ebola vaccine
United States Department of Health and Human Servi...'s picture
HHS
10/04/2016 - 07:13
HHS pursues tests for radiation absorbed in nuclear emergency
United States Department of Health and Human Servi...'s picture
HHS
09/29/2016 - 13:27
For bioterrorism preparedness, HHS sponsors inhaled chlorine antidote
United States Department of Health and Human Servi...'s picture
HHS
09/26/2016 - 08:27
BARDA awards funding to speed development of Zika vaccine
United States Department of Health and Human Servi...'s picture
HHS
09/19/2016 - 04:00
HHS forges strategic partnerships with two global companies to develop new antibiotics
United States Department of Health and Human Servi...'s picture
HHS
09/07/2016 - 06:20
HHS accelerates development of mRNA-based Zika vaccine
United States Department of Health and Human Servi...'s picture
HHS
09/06/2016 - 14:00
CEL-SCI ANNOUNCES RESIGNATION OF ITS FOUNDER FOR HEALTH REASONS
Cel-Sci's picture
Cel-Sci
09/02/2016 - 14:35
CEL-SCI REPORTS MONTHLY PATIENT ENROLLMENT IN AUGUST FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
09/01/2016 - 08:56
HHS awards $ 19.8 million to Japanese company to accelerate development of a Zika vaccine
United States Department of Health and Human Servi...'s picture
HHS
08/04/2016 - 13:15
Grafix Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal
Osiris's picture
Osiris
08/01/2016 - 05:12
CEL-SCI REPORTS MONTHLY PATIENT ENROLLMENT IN JULY FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
07/20/2016 - 19:37
Psychologist Explains Emotional Appeal is a Crucial Ingredient for a Product's Success
Institute of Food Technologists's picture
Institute of Fo...
07/11/2016 - 10:16
CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE CANCER IMMUNOTHERAPY IN COMBINATION WITH RADIATION AND/OR CHEMOTHERAPY
Cel-Sci's picture
Cel-Sci
07/05/2016 - 08:47
CEL-SCI REPORTS MONTHLY PATIENT ENROLLMENT IN JUNE FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
06/30/2016 - 05:36
Changing Air Force health care through innovation
US Air Force's picture
US Air Force
06/01/2016 - 18:25
CEL-SCI REPORTS MONTHLY PATIENT ENROLLMENT IN MAY FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
05/31/2016 - 15:44
CEL-SCI TO PRESENT AT THE FIFTH ANNUAL MARCUM MICROCAP CONFERENCE
Cel-Sci's picture
Cel-Sci
04/25/2016 - 01:21
SIGA Announces Enrollment of First Patients in the Final Cohort of Phase III Study of Tecovirimat
SIGA Technologies's picture
SIGA Technologies
04/12/2016 - 00:19
SIGA Emerges from Chapter 11 Bankruptcy Protection
SIGA Technologies's picture
SIGA Technologies
03/16/2016 - 23:58
SIGA Commences Clinical Study for Intravenous (IV) Formulation of TPOXX
SIGA Technologies's picture
SIGA Technologies
02/24/2016 - 00:45
FDA Concurs on Clinical Dose for SIGA's Tecovirimat Antiviral
SIGA Technologies's picture
SIGA Technologies
01/19/2016 - 06:07
Osiris Responds to Statements about the Company Recently Posted to Several Websites
Osiris's picture
Osiris
01/05/2016 - 18:25
Osiris Provides Update on Coverage for Grafix®
Osiris's picture
Osiris
01/05/2016 - 14:45
CEL-SCI REPORTS RECORD YEAR FOR PATIENT ENROLLMENT WITH 75% INCREASE IN ITS GLOBAL PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci